Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q28192328)
Watch
English
Bivalirudin: a direct thrombin inhibitor
scientific article (publication date: 2002)
In more languages
edit
Statements
instance of
scholarly article
0 references
review article
1 reference
stated in
Europe PubMed Central
title
Bivalirudin: a direct thrombin inhibitor
(English)
0 references
author name string
Timothy D Gladwell
series ordinal
1
0 references
language of work or name
English
0 references
publication date
January 2002
0 references
published in
Clinical Therapeutics
0 references
volume
24
0 references
issue
1
0 references
page(s)
38-58
0 references
cites work
Unstable angina pectoris
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy, and safety
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Protection of factor Xa from neutralization by the heparin-antithrombin complex
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Direct thrombin inhibitors for treatment of arterial thrombosis: potential differences between bivalirudin and hirudin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Thrombin and antithrombotics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New anticoagulants
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New anticoagulant drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Anion-binding exosite of human alpha-thrombin and fibrin(ogen) recognition
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with bivalirudin (Hirulog) as compared with heparin during coronary angioplasty for unstable or postinfarction angina. Hirulog Angioplasty Study Investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized comparison of bivalirudin and heparin in patients undergoing coronary angioplasty for postinfarction angina. Hirulog Angioplasty Study Investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplasty
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bivalirudin compared with heparin during coronary angioplasty for thrombus-containing lesions
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Usefulness and tolerability of hirulog, a direct thrombin-inhibitor, in unstable angina pectoris.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hirulog in the treatment of unstable angina. Results of the Thrombin Inhibition in Myocardial Ischemia (TIMI) 7 trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical outcomes of bivalirudin for ischemic heart disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized double-blind comparison of two doses of Hirulog with heparin as adjunctive therapy to streptokinase to promote early patency of the infarct-related artery in acute myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of reteplase with alteplase for acute myocardial infarction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparative safety profiles of hirulog and heparin in patients undergoing coronary angioplasty. The Hirulog Angioplasty Study Investigators
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0149-2918%2802%2985004-4
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0149-2918(02)85004-4
0 references
PubMed publication ID
11833835
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
